Back to Search
Start Over
Bibliometric analysis of N6-methyladenosine in cancer: landscapes, highlights and trending topics.
- Source :
- Future Oncology; Jun2022, Vol. 18 Issue 17, p2141-2153, 13p
- Publication Year :
- 2022
-
Abstract
- Background: N6-methyladenosine (m6A) is crucial in cancer and is being intensively studied. Aim: This bibliometric analysis seeks a broad picture of the role of m6A in cancer to guide and broaden future research. Methods: Publications were retrieved from Web of Science Core Collection and PubMed from 2000 to 2021, with keywords 'm6A' and 'cancer', and analyzed in biblioshiny and VOSviewer. Results: A total of 1013 documents were included, and China and the USA were the top countries with close collaboration. Mechanisms and predictive biomarkers of m6A regulator genes were highlighted. Cross-integration of m6A and other research hot spots, including 'immunotherapy', 'hypoxia' and 'polymorphism', were frontiers of m6A in cancer. Conclusion: This bibliometric study offered an updated perspective on m6A in cancer. [ABSTRACT FROM AUTHOR]
- Subjects :
- BIBLIOMETRICS
RESEARCH funding
TUMORS
ADENOSINES
Subjects
Details
- Language :
- English
- ISSN :
- 14796694
- Volume :
- 18
- Issue :
- 17
- Database :
- Complementary Index
- Journal :
- Future Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 156651892
- Full Text :
- https://doi.org/10.2217/fon-2022-0086